Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease.
Open Access
- 1 October 1991
- Vol. 32 (10) , 1151-1155
- https://doi.org/10.1136/gut.32.10.1151
Abstract
The incorporation of the fatty acids in fish and olive oil into the colonic mucosa of patients with inflammatory bowel disease was examined during 12 weeks' dietary supplementation with the oils, and the influence on colonic mucosal prostaglandin and thromboxane generation was measured. With a dietary supplement of 18 g fish oil daily, concentrations of the major polyunsaturated fatty acids in fish oil, eicosapentaenoic acid and docosahexaenoic acid, were significantly raised in mucosal lipids. The first time these were measured, after three weeks' supplementation, the mean increases in eicosapentaenoic and docosahexaenoic acid were seven fold and 1.5 fold respectively, and these increases were maintained during the 12 week study. Arachidonic acid values fell throughout the study and this reduction was significant at 12 weeks. Mucosal prostaglandin E2 (PGE2), thromboxane B2, and 6-keto prostaglandin F1 alpha synthesis were suppressed, and this reached significance (p less than 0.05) at three and 12 weeks for PGE2 and at 12 weeks for thromboxane B2. The predominant fatty acid in olive oil is oleic acid. Supplementation with 18 g/day resulted in a significant increase in oleic acid in colonic mucosa at 12 weeks (p less than 0.05) and a fall in stearic acid and docosahexaenoic acid; there was no significant change in eicosanoid synthesis. It is concluded that colonic lipids and prostaglandin and thromboxane synthesis can be readily altered by dietary supplementation with fish oil. The extent of incorporation of the fatty acids present in oils is dependent upon the individual fatty acid.Keywords
This publication has 31 references indexed in Scilit:
- Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease.Gut, 1990
- Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis.Gut, 1990
- Therapeutic potential of fish oil in the treatment of ulcerative colitisAlimentary Pharmacology & Therapeutics, 1989
- Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease.Gut, 1989
- The Effect of Dietary Supplementation with n—3 Polyunsaturated Fatty Acids on the Synthesis of Interleukin-1 and Tumor Necrosis Factor by Mononuclear CellsNew England Journal of Medicine, 1989
- In vivo effects of orally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis.Gut, 1987
- Increased arachidonic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitis.Gut, 1987
- Dietary fish oils reduce plasma levels of platelet activating factor precursor (lyso-PAF) in ratsLife Sciences, 1986
- Imbalance of prostacyclin and thromboxane synthesis in Crohn's disease.Gut, 1983
- Polyunsaturated fatty acids, hyperlipidemia, and thrombosis.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1982